Persistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus

American Journal of Tropical Medicine and Hygiene

Volumn 89, Issue 5, 2013, Pages 996-1000

  Murray, Kristy O ^a   Garcia, Melissa N ^a   Yan, Chris ^b   Gorchakov, Rodion ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; COMORBIDITY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; SOCIAL BEHAVIOR; VIRUS INFECTION; WEST NILE VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TEXAS; TIME FACTORS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84888589374     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0232     Document Type: Article

References (23)

1. Craven RB, Roehrig JT, 2001. West Nile virus. JAMA 344: 1858-1859.
2. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ, 2002. West Nile virus. Lancet Infect Dis 2: 519-529.
3. Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C, 2000. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. J Clin Microbiol 38: 2232-2239.
4. Papa A, Danis K, Athanasiasdou A, Delianidou M, Panagiotopoulos T, 2011. Persistence of West Nile virus immunoglobulin M antibodies, Greece. J Med Virol 83: 1857-1860.
5. Roehrig JT, Nash D, Maldin B, Labowitz A, Martin DA, Lanciotti RS, Campbell GL, 2003. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 9: 376-396.
6. Murray KO, Baraniuk S, Resnick M, Arafat R, Kilborn C, Cain K, Shallenberger R, York T, Martinez D, Malkoff M, McNeely W, Elgawley N, Khuwaja SA, 2008. Clinical investigation of hospitalized West Nile virus cases in Houston, 2002-2004. Vector Borne Zoonotic Dis 8: 167-174.
7. Johnson AJ, Martin DA, Karabatsos N, Roehrig JT, 2000. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol 38: 1831.
8. Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT, 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for rountine diagnosis of arboviral infections. J Clin Microbiol 38: 1823-1826.
9. Murray KO, Walker C, Herrington E, Lewis JA, McCormick J, Beasley D, Tesh RB, Fisher-Hoch S, 2010. Persistent infection with West Nile virus years after initial infection. J Infect Dis 201: 2-4.
10. Rawlins ML, Swenson EM, Hill HR, Litwin CM, 2007. Evaluation of an enzyme immunoassay for detection of immunoglobulin M antibodies to West Nile virus and the importance of background subtraction in detecting nonspecific reactivity. Clin Vaccine Immunol 14: 665-668.
11. Prince HE, Tobler LH, Lape-Nixon M, Foster GA, Stramer SL, Busch MP, 2005. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol 43: 4316-4320.
12. McAllister-Sistilli CG, Caggiula AR, Knopf S, Rose CA,Miller AL, Donny EC, 1998. The effects of nicotine on the immune system. Psychoneuroendocrinology 23: 175-187.
13. Cook RT, 1998. Alcohol abuse, alcoholism, and damage to the immune system - a review. Alcohol Clin Exp Res 22: 1927-1942.
14. Hakim FT, Gress RE, 2007. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens 70: 179-189.
15. Murray K, Baraniuk S, Resnick M, Arafat R, Kilborn C, Cain K, Shallenberger R, York TL, Martinez D, Hellums JS, Hellums D, Malkoff M, Elgawley N, McNeely W, Khuwaja SA, Tesh RB, 2006. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 134: 1325-1332.
16. Wertheimer AM, Uhrlaub JL, Hirsch A, Medigeshi G, Sprague J, Legasse A, Wilk J, Wiley CA, Didier P, Tesh RB, Murray KO, Axthelm MK, Wong SW, Nikolich-Žugich J, 2010. Immune response to the West Nile virus in aged non-human primates. PLoS One 5: e15514.
17. Tesh RB, Siirin M, Guzman H, Travassos da Rosa APA, Wu X, Duan T, Lei H, Nunes MR, Xiao S-Y, 2005. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis 192: 287-295.
18. Tonry JH, Xiao S-Y, Siirin M, Chen H, Travassos APA, Tesh RB, 2005. Persistent shedding of West Nile virus in the urine of experimentally infected hamsters. Am J Trop Med Hyg 73: 320-324.
19. Pogodina VV, Frolova MP, Malenko GV, Fokina GI, Koreshkova GV, Kiseleva LL, Bochkova NG, Ralph NM, 1983. Study on West Nile virus persistence in monkeys. Arch Virol 75: 71-86.
20. Siddharthan V, Wang H, Motter NE, Hall JO, Skinner RD, Skirpstunas RT, Morrey JD, 2009. Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. J Virol 83: 4251-4261.
21. Appler KK, Brown AN, Stewart BS, Behr MJ, Demarest VL, Wong SJ, Bernard KA, 2010. Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One 5: e10649.
22. Stewart BS, Demarest VL, Wong SJ, Green S, Bernard KA, 2011. Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection. BMC Immunol 12: 6.
23. Quiroga JA, Herrero M, Castillo I, Navas S, Pardo M, Carreño V, 1994. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic HCV. J Infect Dis 170: 669-673.